Weight Loss
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
Team Metabolic Health As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies…
What can a wonder drug maker and a phone maker have in common? Their fall from grace
Team Metabolic Health The meteoric rise of Denmark’s Novo Nordisk A/S from century-old insulin producer to Europe’s most valuable company…
Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free
Team Metabolic Health Eli Lilly (LLY.N) has said its weight-loss drug helped nearly 99% of patients remain diabetes-free after three…
What to Expect During and After a Weight Loss Injection Treatment
Team Metabolic Health At some point, many people can attest to attempting to lose weight. In fact, it’s estimated that 45…
Ozempic can even cut the risk of Alzheimer’s disease, study says
Team Metabolic Health A new study found that semaglutide, the active ingredient in Ozempic and Wegovy, lowered the risk of…
Weight loss drugs could help with alcohol and opioid addiction, new study shows
Team Metabolic Health Diabetes and weight loss drugs like Mounjaro and Ozempic may also help patients suffering from addiction, according to a new study. In…
10 reasons why you are gaining weight despite exercise and healthy diet: Nutritionist lists common mistakes to avoid
Team Metabolic Health So, you hit the gym or work out from home and eat healthy, but still gain a…
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
Team Metabolic Health An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S.,…
Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the patent expiry of Novo Nordisk’s blockbuster brands Ozempic and Wegovy
Team Metabolic Health Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the…
MUSC involved in study on device that caused ‘statistically significant weight loss’
Team Metabolic Health A device called Epitomee caused “statistically significant weight loss” in a 24-week trial involving nine study sites,…
Weight Loss drugs may alter treatment paradigm for chronic disorders, say experts
Team Metabolic Health Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and metabolic…
Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
Team Metabolic Health U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far…
Lilly’s Zepbound outshines Wegovy in weight loss head-to-head trial
Team Metabolic Health Wegovy was approved in the US as a treatment for heart disease in March, while Zepbound is…
Exploring carnivore diet: The zero-carb trend for rapid weight loss
Team Metabolic Health The carnivore diet, a zero-carb trend, is gaining attention for rapid weight loss. But while it offers…
New health care policy changes will soon affect weight-loss drugs
Team Metabolic Health The weight-loss industry may become more accessible to the average American. Medications that lower blood sugar levels…